Avalet 20 mg (Avatrombopag) is a revolutionary oral medication designed to treat thrombocytopenia (low platelet count) in adults with chronic liver disease (CLD) who are scheduled to undergo medical or dental procedures. Avatrombopag, the active ingredient in Avalet, is a thrombopoietin receptor agonist that stimulates platelet production in the bone marrow, helping to increase platelet counts and reduce the risk…
Abeclib-150mg, powered by Abemaciclib, is a cutting-edge medication designed to treat advanced Treatment for Breast Cancer. This powerful drug, part of the CDK4/6 inhibitor class, works by targeting and blocking certain proteins in cancer cells, stopping their growth and division. It is specifically approved for hormone receptor-positive (HR+) and HER2-negative advanced breast cancer, either as a standalone treatment or combined…
Acalabrutinib, marketed under the brand name Acaluxen 100mg, is a breakthrough medication used in the treatment of specific Blood Cancer therapy, including mantle cell lymphoma (MCL) and chronic lymphocytic leukaemia (CLL). As a second-generation Bruton’s tyrosine kinase (BTK) inhibitor, Acalabrutinib works by blocking the activity of BTK, a protein that contributes to the growth and survival of cancer cells. This…
Afanix 40 Mg, containing the active ingredient Afatinib, is a powerful medication used in the treatment of non-small cell lung cancer (NSCLC). It belongs to the group of medications known as tyrosine kinase inhibitors (TKIs) that target and block specific proteins responsible for cancer cell growth. This makes Afanix 40 Mg an essential treatment option for patients with Medication Of…
Alecnib 150 Mg contains Alectinib, a highly effective oral medication designed to treat ALK-positive Non Small Cell Lung Cancer Treatment (NSCLC). Alectinib is a next-generation tyrosine kinase inhibitor (TKI) specifically engineered to block the action of anaplastic lymphoma kinase (ALK), a protein responsible for cancer cell growth in certain lung cancers. Alecnib has proven to be a breakthrough treatment for…
Axinix (Axitinib) is a cutting-edge cancer treatment specifically designed to target advanced renal cell carcinoma (kidney cancer). Available in 1mg and 5mg dosages, Axinix works as a tyrosine kinase inhibitor (TKI), blocking the growth and spread of cancer cells by interfering with the proteins responsible for tumour growth and blood vessel development. This targeted therapy provides a powerful, focused approach…
Axinix 5 mg contains Axitinib , a potent oral medication specifically developed to treat advanced renal cell carcinoma (RCC) , a type of kidney cancer. Axitinib belongs to the class of drugs known as tyrosine kinase inhibitors (TKIs), which work by blocking the proteins that encourage cancer cells to grow and spread. Axinix is often used in cases where other…
Baricinix 4 mg (baricitinib) is a powerful oral medication designed to treat moderate to severe rheumatoid arthritis (RA) in adults who have not responded well to other treatments. Baricitinib, the active ingredient in Baricinix, is a Janus kinase (JAK) inhibitor, which reduces inflammation and prevents the immune system from attacking the joints. Additionally, Baricinix 4 mg has been approved for…
Baricinix 4 mg and 2 mg , powered by Baricitinib , is a breakthrough oral medication used to treat moderate to severe Therapy for rheumatoid arthritis and COVID-19 complications in certain hospitalized patients. As a Janus kinase (JAK) inhibitor, Baricinix targets specific enzymes that cause inflammation in autoimmune diseases like rheumatoid arthritis. It has recently been approved for managing severe…
Barigen 4 Mg, containing Baricitinib, is a powerful oral medication designed to treat moderate to severe Therapy for Rheumatoid Arthritis and certain complications of COVID-19. Baricitinib belongs to the class of drugs known as Janus kinase (JAK) inhibitors, which target the inflammation processes that cause joint damage and pain in autoimmune conditions. It also plays a critical role in reducing…
Barinib 2 mg (baricitinib) is an innovative oral medication designed to treat moderate to severe rheumatoid arthritis (RA) in adults who have not responded well to other treatments. The active ingredient, Baricitinib, is a Janus kinase (JAK) inhibitor that helps reduce inflammation by targeting specific enzymes responsible for the overactive immune response in rheumatoid arthritis. Barinib 2 mg offers an…
Briganix 180 mg (Brigatinib) is a cutting-edge oral medication designed to treat ALK-positive non-small cell lung cancer (NSCLC) in adults. Brigatinib is a next-generation tyrosine kinase inhibitor (TKI) that targets the abnormal anaplastic lymphoma kinase (ALK) gene mutation, a key driver of cancer cell growth in ALK-positive lung cancer. This medication is particularly effective for patients whose cancer has progressed…
Briganix 90 mg (Brigatinib) is an advanced oral medication specifically designed for the treatment of ALK-positive non-small cell lung cancer (NSCLC) in adults. Brigatinib is a next-generation tyrosine kinase inhibitor (TKI) that targets the abnormal anaplastic lymphoma kinase (ALK) gene mutation, a key driver of cancer cell growth in some forms of lung cancer. Briganix 90 mg is especially effective…
Caboxen 20 mg , featuring the active ingredient Cabozantinib , is a cutting-edge oral medication designed to treat advanced renal cell carcinoma (RCC) and medical thyroid cancer (MTC). As part of the tyrosine kinase inhibitors (TKI) class, Caboxen targets multiple receptors involved in tumour growth, effectively slowing or stopping cancer progression. With its proven efficacy, Caboxen offers a powerful solution…
Cabozanix (Cabozantinib) is a cutting-edge oral medication designed to treat advanced stages of various cancers, including renal cell carcinoma (RCC), hepatocellular carcinoma (HCC), and medullary thyroid cancer (MTC). As a tyrosine kinase inhibitor (TKI), Cabozantinib blocks specific proteins that drive the growth and spread of cancer cells. Available in 20 mg, 60 mg, and 80 mg strengths, Cabozanix is a…
Capmaxen-200MG is a highly effective antibiotic designed to tackle many bacterial infections. With its powerful 200MG formulation, this medication is ideal for treating common infections such as respiratory tract infections, urinary tract infections, and skin infections. Capmaxen-200MG works by inhibiting bacterial growth, allowing your immune system to clear the infection and helping you feel better faster. Whether you’re…
Cerinib 150 mg contains Ceritinib, a powerful targeted therapy specifically designed for the treatment of ALK-positive non-small cell lung cancer (NSCLC). It is an oral medication used to manage advanced stages of lung cancer, particularly in patients whose cancer has spread to other parts of the body (metastatic) and who may have developed resistance to prior treatments. Ceritinib works by…
Crizocent 250mg (Crizotinib) is a highly effective targeted therapy specifically designed to treat advanced non-small cell lung cancer (NSCLC) that is ALK-positive (anaplastic lymphoma kinase) or ROS1-positive. This innovative medication works by blocking the activity of proteins (ALK and ROS1) that promote cancer cell growth, making it an essential treatment for patients with these specific genetic mutations. Crizocent is trusted…
Elopag 25mg & 50mg, powered by the active ingredient Eltrombopag, is a highly effective oral medication used to treat chronic immune thrombocytopenia (ITP), aplastic anemia, and chronic hepatitis C-related thrombocytopenia. Thrombocytopenia occurs when your platelet count is too low, leading to excessive bruising or bleeding. Elopag works by increasing platelet production, helping to restore a safe platelet level in the…
Hertinib-40mg (Neratinib) is an advanced oral medication specifically designed to treat early-stage HER2-positive breast cancer in patients who have completed prior trastuzumab-based therapy. As a targeted therapy, Hertinib-40mg works by inhibiting the HER2 protein, which is responsible for the growth and spread of cancer cells. By blocking this protein, Hertinib-40mg helps prevent cancer from returning, offering patients improved outcomes and…
Ibrucent 140 mg (Ibrutinib) is an innovative oral medication used to treat specific types of blood cancers, including Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma (MCL), and Waldenström’s Macroglobulinemia (WM). Ibrutinib, the active ingredient in Ibrucent, is a Bruton’s Tyrosine Kinase (BTK) inhibitor. This targeted therapy blocks the activity of BTK proteins, which are crucial for the growth and survival…
Ibruxen Capsule 140mg, containing Ibrutinib 140mg, is a powerful oral medication for certain blood cancers. Known for its effectiveness, it primarily targets chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and Waldenström's macroglobulinemia. Developed to inhibit Bruton's tyrosine kinase (BTK), Ibruxen helps prevent cancer cells from growing and multiplying, offering hope for those dealing with these challenging conditions.
Ivosenib 250mg (Ivosidenib 250mg) is a groundbreaking medication designed to Treatment Acute Myeloid Leukemia (AML), particularly in patients with a specific genetic mutation called IDH1. This targeted therapy offers new hope for patients whose cancer is resistant to conventional treatments, providing a highly specialized approach that can transform the course of this aggressive blood cancer.
Lenvanix (Lenvatinib) is a powerful cancer-fighting medication available in 10 mg and 4 mg doses. As a targeted therapy, Lenvanix plays a critical role in treating advanced thyroid cancer, liver cancer (hepatocellular carcinoma), and renal cell carcinoma (kidney cancer). This oral medication works by inhibiting proteins in cancer cells that promote tumour growth, helping to slow or even stop the…
Lenvaxen 10 mg (Lenvatinib) is an innovative oral medication designed to treat several types of advanced cancers, including thyroid cancer, renal cell carcinoma (RCC), and hepatocellular carcinoma (HCC). The active ingredient, Lenvatinib, is a multi-targeted tyrosine kinase inhibitor (TKI) that works by blocking the signals that promote the growth of cancer cells and the formation of blood vessels that supply…
Lenvaxen (Lenvatinib) is a powerful oral medication used to treat various types of cancer, including thyroid cancer, renal cell carcinoma (RCC), and hepatocellular carcinoma (HCC). The active ingredient in Lenvaxen is lapatinib, a tyrosine kinase inhibitor (TKI) that works by blocking multiple enzymes responsible for the growth and spread of cancer cells. This targeted approach helps slow down tumour growth,…
Lenvaxen 4mg (Lenvatinib) is a powerful, targeted cancer therapy specifically designed to treat advanced thyroid cancer, hepatocellular carcinoma (liver cancer), and renal cell carcinoma (kidney cancer). This innovative medication inhibits specific proteins that promote tumour growth and spread, slowing cancer progression. Lenvaxen 4mg has become a trusted choice for oncologists worldwide due to its efficacy in targeting multiple cancer types,…
Lorbrexen 100 mg (lorlatinib) is an innovative oral medication used to treat non-small cell lung cancer (NSCLC) in patients with a specific gene mutation known as ALK-positive . This cutting-edge therapy is designed to slow the progression of Cancer, offering hope for patients in the advanced stages of Treatment For Lung Cancer where other treatments may have failed. With Lorbrexen,…
Lorbrexen (Lorlatinib 100mg) is an innovative cancer therapy specifically designed to treat non-small cell lung cancer (NSCLC) that is positive for ALK (anaplastic lymphoma kinase) mutations. This targeted therapy is highly effective in managing advanced stages of ALK-positive NSCLC, especially in patients whose cancer has progressed despite prior treatment with other ALK inhibitors. Lorbrexen works by blocking the activity of…
Unlock a new avenue of hope in targeted cancer therapy with Mobocertinib 40 mg (Moboxen), a cutting-edge therapy specifically designed for patients with non-small cell lung cancer (NSCLC) harboring specific EGFR mutations. With a focus on precision medicine, Mobocertinib offers a targeted approach that aims to inhibit tumor growth while minimizing side effects, making it a valuable option for those…
Niranib 100mg (Niraparib) is an advanced oral medication used for the maintenance treatment of ovarian, fallopian tube, and primary peritoneal cancers. It's part of a group of cancer treatments known as PARP inhibitors, which target and destroy cancer cells by preventing them from repairing their DNA. Niranib offers new hope for patients who are in remission following successful treatment with…
Obetix 5 mg (Obeticholic Acid) is a breakthrough medication designed to treat primary biliary cholangitis (PBC), a chronic liver disease that causes inflammation and damage to the bile ducts. Obeticholic acid, the active ingredient in Obetix, works by activating the farnesoid X receptor (FXR), a key regulator in bile acid metabolism. This helps reduce liver inflammation and damage, slowing the…
Olanib 50mg & 150mg (Olaparib) is a leading-edge oral medication used to treat various cancers, specifically ovarian, breast, prostate, and pancreatic cancers. This powerful drug belongs to a class of treatments known as PARP Inhibitor For Prostate Cancer (Poly ADP-Ribose Polymerase inhibitors). It is designed to stop cancer cells from repairing themselves, slowing tumour growth and enhancing survival rates.
Osicent 80mg (Osimertinib) is a groundbreaking medication designed for the treatment of non-small cell lung cancer (NSCLC) in patients with specific epidermal growth factor receptor (EGFR) mutations, including the resistant T790M mutation. As a third-generation EGFR inhibitor, Osicent 80mg offers a targeted approach that is proven to be effective in treating advanced and metastatic stages of NSCLC, particularly when the…
Osimert 80mg, containing the active ingredient Osimertinib, is a potent medication for treating non-small cell lung cancer (NSCLC). As a third-generation tyrosine kinase inhibitor (TKI), Osimertinib specifically targets and inhibits the activity of epidermal growth factor receptor (EGFR) mutations, including T790M resistance mutations, which are commonly associated with the progression of New Cancer Treatment For Lung Cancer. This targeted approach…
Palbocent 125 mg (Palbociclib) is an innovative oral medication used to treat hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced or metastatic breast cancer. Palbociclib, the active ingredient in Palbocent, is a selective inhibitor of cyclin-dependent kinases (CDK) 4 and 6, enzymes that play a crucial role in the growth and division of cancer cells. By blocking…
Palboxen 125mg, containing the active ingredient Palbociclib, is a groundbreaking medication specifically designed for the treatment of hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer. As a cyclin-dependent kinase (CDK) 4/6 inhibitor, Palboxen 125mg is vital in slowing down the growth and spread of cancer cells, offering hope to patients whose cancer has progressed after previous treatments. When used…
Ponatinix 45 mg (Ponatinib) is a cutting-edge, targeted therapy used to treat patients with chronic myeloid leukaemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL), particularly those who have become resistant to previous treatments. Ponatinib, the active ingredient in Ponatinix, is a third-generation tyrosine kinase inhibitor (TKI) that is especially effective against the T315I mutation, which makes many forms…
Ponaxen (Ponatinib) is a powerful medication designed to treat certain types of blood cancers, including chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL), that have shown resistance to other treatments. Available in both 45mg and 15mg doses, Ponaxen offers patients a cutting-edge approach by targeting abnormal proteins driving cancer growth, helping to control and manage the disease.
Renib 40 mg is a highly effective oral medication used to treat meertastatic castration-resistant prostate cancer (mCRPC) and non-metastatic castration-resistant prostate cancer (nmCRPC). The active ingredient, Enzalutamide, is a powerful androgen receptor inhibitor that works by blocking male hormones like testosterone from stimulating the growth of prostate cancer cells. This targeted therapy helps slow the progression of prostate cancer, offering…
Rizonib 250 mg (Crizotinib) is an advanced oral medication used to treat non-small cell lung cancer (NSCLC) that is ALK-positive (anaplastic lymphoma kinase-positive) or ROS1-positive. Crizotinib, the active ingredient in Rizonib, is a targeted therapy that works by inhibiting the abnormal proteins responsible for driving the growth of cancer cells. This powerful treatment offers hope for patients with advanced or…
Selinex 20mg (Selinexor) is a groundbreaking oral medication designed to treat multiple myeloma, diffuse large B-cell lymphoma (DLBCL), and other aggressive cancers. Selinexor, the active ingredient in Selinex, belongs to a new class of drugs known as Selective Inhibitors of Nuclear Export (SINE). It works by targeting and inhibiting XPO1, a protein involved in the export of tumor-suppressing proteins from…
Sotoxen 120mg (Sotorasib) is a revolutionary medication designed to target and treat non-small cell lung cancer (NSCLC) with a specific genetic mutation. This targeted therapy is specifically formulated for patients whose tumors carry the KRAS G12C mutation, a previously untreatable form of lung cancer. Sotoxen works by inhibiting the KRAS protein, slowing down the growth of cancer cells, and providing…
Tagrix-80mg (Osimertinib) is a life-changing medication designed to target and treat non-small cell lung cancer (NSCLC) that has specific EGFR (epidermal growth factor receptor) mutations. As an advanced third-generation EGFR inhibitor, it offers hope to patients who have developed resistance to earlier treatments. Tagrix is especially effective against tumors that harbor the T790M mutation, providing a tailored approach to Treatment…
Tucaxen 150mg, with the active ingredient Tucatinib, is a cutting-edge oral medication used in Her2 positive breast cancer treatment. Designed to target and inhibit the growth of cancer cells that overexpress the HER2 protein, Tucaxen 150mg is a key player in modern cancer therapy. It is often prescribed in combination with other cancer treatments, such as trastuzumab and capecitabine, to…
Venex 100mg, powered by the active ingredient Venetoclax, is a revolutionary oral treatment for specific blood cancers, including chronic lymphocytic leukaemia (CLL) and Acute Myeloid Leukemia (AML). This advanced medication targets and inhibits the BCL-2 protein, which plays a crucial role in helping cancer cells survive. By blocking this protein, Venex 100mg promotes cancer cell death, offering a highly effective…
Ventoxen 100mg, containing Venetoclax, is a breakthrough oral medication used to treat specific blood cancer treatment, including chronic lymphocytic leukaemia (CLL) and acute myeloid leukaemia (AML). This targeted therapy is designed to inhibit the BCL-2 protein, which plays a key role in cancer cell survival. It helps restore the body's natural ability to trigger cell death in cancerous cells. Ventoxen…
Wedica 100 mg (Trelagliptin) is an innovative, once-weekly oral medication designed to help control blood sugar levels in adults with Type 2 Diabetes. The active ingredient, Trelagliptin, is a DPP-4 inhibitor (dipeptidyl peptidase-4) that increases the levels of incretin hormones, which help regulate glucose metabolism. This convenient once-weekly tablet helps reduce blood sugar spikes after meals, improves overall glycemic control,…